Cynthia Yee, Principal, Vensana Capital
Cynthia Yee is a Principal at Vensana Capital. Cynthia brings over a decade of investing, operating, and public equities experience to Vensana. Prior to joining Vensana, she served as a Principal at Windham Venture Partners, where she led the firm’s investments in Cartiva Medical (acquired), ClarVista Medical (acquired), Personal Genome Diagnostics (acquired) and NeuSpera Medical, and was previously an Associate at NEA focused on investments in medical devices and healthcare services. She also gained operating experience as Director of Business Development & Strategic Marketing at Epix Therapeutics (fka Advanced Cardiac Therapeutics, acquired) and medtech incubator D3DC. Cynthia began her career in public equities, covering medical devices at Piper Jaffray and biotechnology at Pacific Growth Equities. Cynthia currently serves on the board of directors of SpyGlass Pharma. She graduated with a BA in Integrative Biology and a BS in Business Administration at the Haas School of Business at the University of California, Berkeley.